Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Nature Communications
|
March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
Craig A Magaret, Li Li, Allan C deCamp, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials
Carolyn Williamson, Lyle Curry, Nonhlanhla N Mkhize, et al.
Nature Immunology
|
October 30, 2021
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
Vincent Dussupt, Rajeshwer S Sankhala, Letzibeth Mendez-Rivera, et al.
Nature Medicine
|
February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
Vincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Nature Communications
|
January 3, 2024
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Rajeshwer S Sankhala, Kerri G Lal, Jaime L Jensen, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
M Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Cell Reports
|
December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
M Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Immunity
|
March 17, 2019
Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual
Shelly J Krebs, Young D Kwon, Chaim A Schramm, et al.
Plos Medicine
|
April 8, 2015
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis
Soo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Nature
|
April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Nature Communications
|
March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
Craig A Magaret, Li Li, Allan C deCamp, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials
Carolyn Williamson, Lyle Curry, Nonhlanhla N Mkhize, et al.
Nature Immunology
|
October 30, 2021
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
Vincent Dussupt, Rajeshwer S Sankhala, Letzibeth Mendez-Rivera, et al.
Nature Medicine
|
February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
Vincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Nature Communications
|
January 3, 2024
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Rajeshwer S Sankhala, Kerri G Lal, Jaime L Jensen, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
M Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Cell Reports
|
December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
M Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Immunity
|
March 17, 2019
Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual
Shelly J Krebs, Young D Kwon, Chaim A Schramm, et al.
Plos Medicine
|
April 8, 2015
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis
Soo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Nature
|
April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Page
of 12